Overlap Syndrome. José M. Marin Hospital Universitario Miguel Servet Zaragoza, Spain.

Similar documents
Bi-Level Therapy: Boosting Comfort & Compliance in Apnea Patients

SLEEP DISORDERED BREATHING AND CHRONIC LUNG DISEASE: UPDATE ON OVERLAP SYNDROMES

(To be filled by the treating physician)

NIPPV FOR THE HYPERCAPNIC COPD AND OBSESITY HYPOVENTILATION PATIENT

Average volume-assured pressure support

BiPAPS/TVAPSCPAPASV???? Lori Davis, B.Sc., R.C.P.T.(P), RPSGT

2/13/2018 OBESITY HYPOVENTILATION SYNDROME

OBESITY HYPOVENTILATION SYNDROME: CPAP vs NIV. J. F. Masa San Pedro de Alcántara Hospital Cáceres. Spain

Causes and Consequences of Respiratory Centre Depression and Hypoventilation

OSA and COPD: What happens when the two OVERLAP?

The Effect of Sleep Disordered Breathing on Cardiovascular Disease

Choosing the Appropriate Mode of PAP Therapy in the Perioperative Setting

High Flow Nasal Cannula in Children During Sleep. Brian McGinley M.D. Associate Professor of Pediatrics University of Utah

6/5/2017. Mellar P Davis MD FCCP FAAHPM Geisinger Medical Center Danville, PA

Sleep and the Heart. Physiologic Changes in Cardiovascular Parameters during Sleep

Sleep and the Heart. Rami N. Khayat, MD

Obstructive Sleep Apnea and COPD overlap syndrome. Financial Disclosures. Outline 11/1/2016

Sleep and the Heart Reversing the Effects of Sleep Apnea to Better Manage Heart Disease

more than 50% of adults weigh more than 20% above optimum

Polysomnography (PSG) (Sleep Studies), Sleep Center

Policy Specific Section: October 1, 2010 January 21, 2013

RESPIRATORY FAILURE. Dr Graeme McCauley KGH

Mario Kinsella MD FAASM 10/5/2016

Identification and Treatment of the Patient with Sleep Related Hypoventilation

Sleep Apnea: Vascular and Metabolic Complications

Reasons Providers Use Bilevel

Ron Hosp, MS-HSA, RRT Regional Respiratory Specialist. This program has been approved for 1 hour of continuing education credit.

High Flow Humidification Therapy, Updates.

Obstructive sleep apnea (OSA) is the periodic reduction

Objectives. Health care significance of ARF 9/10/15 TREATMENT OF ACUTE RESPIRATORY FAILURE OF VARIABLE CAUSES: INVASIVE VS. NON- INVASIVE VENTILATION

Chronic NIV in heart failure patients: ASV, NIV and CPAP

SHORT TERM EFFECTS OF NIV ON SLEEP IN END STAGE CF. Moran Lavie MD The national center for Cystic Fibrosis Sheba medical center

CAPNOGRAPHY in the SLEEP CENTER Julie DeWitte, RCP, RPSGT, RST Assistant Department Administrator Kaiser Permanente Fontana Sleep Center

A 74-year-old man with severe ischemic cardiomyopathy and atrial fibrillation

Circadian Variations Influential in Circulatory & Vascular Phenomena

NIV in Acute Respiratory Failure: Where we fail? Dr Shrikanth Srinivasan MD,DNB,FNB,EDIC Consultant, Critical Care Medicine Medanta, The Medicity

Brian Carlin, MD Disclosures 4/6/2014. Speakers bureau Glaxo Smith Kline Boehringer Ingelheim Philips Respironics Forest Breathe Technologies PneumRx

Respiratory Medicine. Some pet peeves and other random topics. Kyle Perrin

TSANZ meeting 01 Apr Physiology of respiratory failure in COPD & OHS. Bhajan Singh MBBS FRACP PhD

Sleep Disordered Breathing: Beware Snoring! Dr T A McDonagh Consultant Cardiologist Royal Brompton Hospital London. UK

Obstructive Sleep Apnea

DECLARATION OF CONFLICT OF INTEREST

Obstructive sleep apnoea How to identify?

Sleep Diordered Breathing (Part 1)

Case 1. Level of difficulty: 2/5

BTS Guideline for Home Oxygen use in adults Appendix 9 (online only) Key Questions - PICO 10 December 2012

Indications for Respiratory Assistance. Sheba Medical Center, ICU Department Nick D Ardenne St George s University of London Tel Hashomer

Anesthetic Challenges in Morbid Obesity

Respiratory Complications of Obesity. Diana Wilson, M.D. ACP Educational Session September 16, 2017

Heart Failure and Sleep Disordered Breathing (SDB) Unhappy Bedfellows

Sleep and Neuromuscular Disease. Sharon De Cruz, MD Tisha Wang, MD

Basic mechanisms disturbing lung function and gas exchange

Challenging Cases in Pediatric Polysomnography. Fauziya Hassan, MBBS, MS Assistant Professor Pediatric Pulmonary and Sleep

Noninvasive Ventilation: Non-COPD Applications

Obstructive Sleep Apnoea and COPD: Can we use auto-titrating ventilator devices?

Wolfram Windisch Lung Center Cologne University of Witten/Herdecke, Germany

Sleep Apnea in Women: How Is It Different?

Respiratory Failure how the respiratory physicians deal with airway emergencies

Acute NIV in COPD and what happens next. Dr Rachael Evans PhD Associate Professor, Respiratory Medicine, Glenfield Hospital

PVDOMICS. Sleep Core. Cleveland Clinic Cleveland, Ohio

Chronic Obstructive Pulmonary Disease (COPD).

Original Article. Keywords: Sleep, REM; Pulmonary disease, chronic obstructive; Anoxemia; Spirometry; Wakefulness

Respiratory Assist Device E0470:

New Government O2 Criteria and Expert Panel. Jennifer Despain, RPSGT, RST, AS

AHA Sleep Apnea and Cardiovascular Disease. Slide Set

Rebecca Mason. Respiratory Consultant RUH Bath

Fabrice Czarnecki, M.D., M.A., M.P.H., FACOEM I have no disclosures to make.

In-Patient Sleep Testing/Management Boaz Markewitz, MD

Is CPAP helpful in severe Asthma?

OXYGEN USE IN PHYSICAL THERAPY PRACTICE. Rebecca H. Crouch, PT,DPT,MS,CCS,FAACVPR

Pathophysiology of COPD 건국대학교의학전문대학원

Sleep Disorders The Effect on our Lives Every Day

3/10/2014. Pearls to Remember. 1) Consequences of OSA related to both arousals and hypoxia. 2) Arousals provoke increased

Exercise Stress Testing: Cardiovascular or Respiratory Limitation?

Respiratory Management of Facioscapulohumeral Muscular Dystrophy. Nicholas S. Hill, MD Tufts Medical Center Boston, MA

WRHA Surgery Program. Obstructive Sleep Apnea (OSA)

11/20/2015. Beyond CPAP. No relevant financial conflicts of interest. Kristie R Ross, M.D. November 12, Describe advanced ventilation options

The most accurate predictors of arterial hypertension in patients with Obstructive Sleep Apnea Syndrome

Pediatric Sleep-Disordered Breathing

Sleep and the Heart. Sleep Stages. Sleep and the Heart: non REM 8/31/2016

Update on Sleep Apnea Diagnosis and Treatment

Oxygen Therapy: When, What and Why

Lecture Notes. Chapter 2: Introduction to Respiratory Failure

Diagnostic and therapeutic approach to coexistent chronic obstructive pulmonary disease and obstructive sleep apnea

Triennial Pulmonary Workshop 2012

Sleep Disordered Breathing

A Comparison of Nocturnal Hypoxia Markers in Apnea Patients with Chronic Obstructive Pulmonary Disease and without it: A Cross-sectional Study

Supplementary Online Content

Novel pathophysiological concepts for the development and impact of sleep apnea in CHF.

Course Handouts & Disclosure

Hypoventilation? Obstructive Sleep Apnea? Different Tests, Different Treatment

THE EFFECTS OF MEDROXYPROGESTERONE ACETATE AND ACETAZOLAMIDE ON THE NOCTURNAL OXYGEN SATURATION IN COPD PATIENTS

Monitoring: gas exchange, poly(somno)graphy or device in-built software?

The effects of sleep-disordered breathing (SDB)

COPD: A Renewed Focus. Disclosures

Sleep disorders in COPD: the forgotten dimension

Sleep apnea as a risk factor for cardiovascular disease

Non-Invasive Ventilation

Medicare C/D Medical Coverage Policy. Respiratory Assist Devices for Obstructive Sleep Apnea and Breathing Related Sleep Disorders

Transcription:

Overlap Syndrome José M. Marin Hospital Universitario Miguel Servet Zaragoza, Spain.

I have nothing to disclose.

Agenda Effects of sleep on breathing Sleep in COPD The Overlap Syndrome Treatment of the Overlap Syndrome

Agenda Effects of sleep on breathing Sleep in COPD The Overlap Syndrome Treatment of the Overlap Syndrome

States of Being Wake REM Sleep NREM Sleep

Effects of sleep on breathing Physiologic Variable Heart rate Respiratory rate Blood pressure Skeletal muscle tone Brain 02 consumption Ventilatory response Temperature Sexual changes NREM Regular Regular Regular Preserved Reduced Normal Normal Rare REM Irregular Irregular Variable Absent Increased Reduced Poikilothermic Frequent

Respiratory Response to Sa02 During Normal Sleep Awake VenDlaDon (L/min) 15 10 5 100 90 80 Oxygen SaturaDon (%) 3/4 2 REM

Respiratory Response to CO 2 During Normal Sleep Douglas NJ Clin Chest Med 1985 VenDlaDon (L/min) 2 0 1 0 30 40 50 End- Ddal PCO(mmHg) Awake Stage 3/4 Stage 2 REM VenElatory response to CO 2 is depressed during NREM sleep Slope of response line is depressed further in REM sleep Set point for response to CO 2 increases during NREM sleep and further in REM sleep - Requires a higher PaCO 2 to semulate respiraeon

Agenda Effects of sleep on breathing Sleep in COPD The Overlap Syndrome Treatment of the Overlap Syndrome

Effects of Sleep on Patients with COPD PaEents with COPD are most profoundly hypoxemic at night (McNicholas WT, Chest 2000). sleep sleep

Effects of Sleep on Patients with COPD Awake Pa0 2 predicts nocturnal desaturaeon beuer than exercise Sa0 2 or wake PaC0 2 (Mulloy E, Chest 1996)

Effects of Sleep on Patients with COPD COPD paeents are more likely to die at night Nocturnal Deaths in COPD, McNicholas BMJ 1984 30 Patient Numbers 20 10 Neoplasms Stroke COPD 0 0700-1500 1500-2300 2300-0700

Copenhagen City Heart Study + Copenhagen General PopulaHon Study: 6.616 COPD

FEV1 not related to SEI Kwon JS et al J COPD 2009;6:441-445

COPD and Poor Sleep: A Two Way Street How does sleep impact COPD? Reduced chemosensievity Reduced pulmonary funceon Impaired muscle performance How does COPD impact sleep? Symptoms cause sleep disturbance Hypoxemia and hypercarpia disturb sleep

Agenda Effects of sleep on breathing Sleep in COPD The Overlap Syndrome Treatment of the Overlap Syndrome

Flenly DC. Clin Chest Med 1985;6:51-61

COPD The diagnostic The classification Stage Criteria* I: Mild FEV 1 /FVC <0.70, FEV 1 80% predicted II: Moderate III: Severe IV: Very Severe FEV 1 /FVC <0.70, 50% FEV 1 <80% predicted FEV 1 /FVC <0.70, 30% FEV 1 <50% predicted FEV 1 <30% predicted or FEV 1 <50% predicted plus chronic respiratory failure Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Carverley P et al. "Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary". Am. J. Respir. Crit. Care Med. 2007; 176:532

OSA The diagnostic The classification Stage Criteria* I: Mild AHI 5 to 15 II: Moderate AHI 15 to 30 III: Severe AHI > 30 *

Overall prevalence of COPD, OSA and overlap syndrome. COPD > 10% Overlap Syndrome > 2% OSA > 20%

Typical pauern during sleep of a paeent with OSA and overlap syndrome OSA alone Sleep onset Overlap In a patient with both snoring and COPD, the O2Sat baseline is reduced during sleep but the saw-tooth pattern is suggestive of obstructive sleep apnea.

Pathways involved in producing nocturnal hypoxemia and hypercapnia in overlap syndrome. COPD OSA Respiratory mechanics - Chest wall muscle tone - Accessory muscle weakness - Short diaphragm length - Lung hyperinflaeon Control of breathing - Central output - Airway muscular tone - CO 2 venelator responses - Chemical drives response Upper airway resistance - Smoking - Neck obesity - Neck fluid accumulaeon - Mucosa inflammaeon V/Q mismatch HypovenDlaDon Hypoxemia Hypercapnia

InteracDons between COPD and OSA. AggravaDng factors for OSA Age Smoking Weight gain Fluid reteneon CorEcosteroids COPD Overlap syndrome ProtecDve factors again OSA Smoking cessaeon Weight loss Sleep postures Bronchodilators

costs in overlap Shaya FT et al Sleep Breath 2009;13:317-323

Health related quality of life in overlap Mermigkis C et al Int J Clin Pract 2007;61(2):207-211

How is the Overlap Syndrome Different than COPD or OSA? PaEents with the Overlap Syndrome have increased risk of complicaeons compared to those with COPD or OSA alone (Gan WQ Thorax, 2004; JM Marin AJRCCM 2010; Greenberg- Dotan S, Sleep Breath 2013) Respiratory failure Pulmonary hypertension HypovenElaEon More severe hypoxemia Diabetes Obesity Death

Accelerated cardiovascular disease in Overlap Smoking Obesity Overlap OSA COPD Hypoxia Oxidative stress TNF-α, IL8, IL-6, PCR Endothelial dysfunction Atherosclerosis Cardiovascular disease

Right Ventricular Remodeling in COPD and Overlap syndrome B. Sharma et al; COPD. 2013 ; 10(1): 4 10.

Agenda Effects of sleep on breathing Sleep in COPD The Overlap Syndrome Treatment of the Overlap Syndrome

Effect of nocturnal nasal oxygen on Sa0 2, systemic and pulmonary artery pressures. (Clement ID Respir Physiol 1992.)

Obesity hypoventilation syndrome on supplemental oxygen and TcPCO2) has climbed from approximately 60 mm Hg (top tracing) to just below 90 mm Hg. Therefore, use of supplemental oxygen in padents with OLS and significant daydme hypercapnia may worsen nocturnal hypercapnia. n supplemental oxygen TcPCO2 climbed from 60 mm Hg (top tracing) to just below 90 m Hg. Therefore, use of supplemental oxygen in patients with COPD and daytime ypercapnia may worsen nocturnal hypercapnia.

Leg movement Respiratory effort Flow Pulse O 2 saturaton Position CPAP 7 cmh2o CPAP 9 cmh2o

Nine- year non randomized prospeceve cohort study Overlap Syndrome: CPAP users - n= 288 Overlap Syndrome : CPAP non users - n= 213 total = 711 COPD - only: n= 210

Marin JM, 2010

Survival curves of COPD patients with COPD-only and Overlap patients Overlap without CPAP showed higher mortality (RR:1.79) and exacerbation with hospitalization compared to COPD-only CPAP users showed no increase risk of death nor exacerbation compared to COPD-only (adjusted for age, sex, BMI, co-morbidities, COPD severity, IAH and diurnal hypersomnolence) Marin JM, AJRCCM 2010

Conclusions of the study - CPAP treatment reduces mortality and also hospitalization in patients with Overlap Syndrome - There are worst mortality and hospitalization in patients with Overlap Syndrome not treated with CPAP than in patients with COPD-only Marin JM, AJRCCM 2010

A. Malhorta et al: J Clin Sleep Med 2013;9(8):767-772

NIV. RCTs are Rare and Small (Bhett SP Int J COPD 2013) 30 COPD paeents (FEV 1 < 50% pred and PaCO 2 < 52mmHg) randomized. (OSA was excluded) AcEve treatment: Bilevel 15/5 cm H 2 0 vs usual care Outcomes: Dyspnea (by TDI) was more improved in the NPPV arm at 6 wks and 3 mos, but not 6 mos. QoL slightly improved in one domain in NPPV arm Pa0 2 increased (+ 2.1 mmhg) in treatment arm, but decreased (- 7.2 mmhg) in control arm. No difference in PaC0 2, 6- minute walk, FEV 1, number of exacerbaeons, or sleep quality (PSQI)

OSA is a reversible co-morbidity! Baseline data BMI= 43.6 Kg/m2 PaO2 = 48 mmhg PaCO2 = 68 mmhg FEV1= 34% pred. AHI= 90/h 5 hosp/ last 12 mo Several co-morbidities 1 year treatment BiPAP + LTOT + global treatment Courtesy of Dr. Machado from Brasil

Overlap Syndrome Treatment 1- Weight loss - Clearly will benefit patients with OSA and obesity - However, in COPD: weight loss is usually associated with increased mortality 2- Oxygen Therapy - Supplemental oxygen is the mainstay of treatment for those with daytime and nocturnal hypoxemia - LTOT decreases mortality if used > 18 h/day - To much oxygen can be dangerous!!!! Poulain M, 2006 GOLD, 2011 - NOTT, 1980 - MRC,1981

Martin RJ, 1999 McNicholas WT, 2004 Ryan S, 2009 - Sampol G, 1996 JMMarin, 2011 Overlap Syndrome Treatment-2 3- Bronchodilators and Corticosteroids - Taken together, previous studies suggest that pharmacological treatment of COPD in Overlap Syndrome will ameliorate nocturnal oxygen desaturation 4- Continuous Positive Airway Pressure (CPAP) - CPAP remains the accepted standard treatment for OSA and for Overlap Syndrome - CPAP plus LTOT can be necessary in some patients - BiPAP vs CPAP

Take home massages Sleep disturbances are common in COPD parecularly insomnia and episodic hypoxaemia. Nocturnal oxygen desaturaeon largely reflects the physiological impact of sleep on venelaeon. Sleep apnea is not especially common in COPD and sleep studies are not rouenely indicated. Management of sleep- related disturbances should focus on opemising management of the underlying COPD and correceng hypoxemia. NIV during sleep can be beneficial in selected cases, parecularly during acute exacerbaeons.